Dr. David G. Schwartz, DO

Dr. Schwartz practices at Cleveland Clinic Martin North Hospital in Stuart, Florida, part of The Cleveland Clinic Foundation.

Dr. Schwartz's NPI, 1225135619, was assigned on September 20, 2006. Dr. Schwartz graduated from New York Institute of Technology College of Osteopathic Medicine - Old Westbury in 1986. Dr. Schwartz holds New York license 173087.

Dr. Schwartz's primary practice is Cleveland Clinic Martin North Hospital, at 200 SE Hospital Ave, Stuart, FL 34994 in Martin County. The practice phone is (772) 287-5200.

Dr. Schwartz's primary practice is Cleveland Clinic Martin North Hospital in Stuart, Florida, part of The Cleveland Clinic Foundation. Dr. Schwartz is also affiliated with Boca Raton Regional Hospital. The medical group on file is Cleveland Clinic Florida. Dmand AI also links Dr. Schwartz to 1 more hospital, 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Schwartz practices, 4 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Schwartz's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Schwartz is board certified in internal medicine by the American Board of Internal Medicine. Dr. Schwartz is licensed in New York.

Dmand AI lists acid reflux, acute gallbladder or bile duct inflammation, acute gastroduodenitis, acute skin infection, aneurysm, anxiety, arthritis and asthma among the conditions Dr. Schwartz treats.

CMS data shows 883 Medicare services from Dr. Schwartz across 10 procedure codes in 2024, for 405 Medicare patients. Medicare paid $40,212 for them. Every service was in an office.

CMS counts 405 Medicare patients who saw Dr. Schwartz in 2024. The largest group is 65 to 74, with 193 patients. 75% of them have high cholesterol, and 63% have high blood pressure. 5% are also on Medicaid. Their average risk score is 1.09, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Schwartz's median patient age at 61, with 51% women.

In 2024, Dr. Schwartz wrote 6,172 Medicare Part D claims for 753 patients. 91% of them were for generic drugs. CMS names the drug for 5,525 of them, across 103 drugs with 11 or more claims each, at $326,061 in total drug cost. In 2023, CMS named 5,656 claims across 102 drugs.

Dr. Schwartz accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Schwartz as offering telehealth.

Dmand AI links 2 papers to Dr. Schwartz in 2016. 2016 was the busiest year, with 2. Dr. Schwartz's most frequent co-authors are Marjan Islam, MD, John Paul Papadopoulos, MD and Gianluca Torregrossa, MD.

CMS Open Payments shows 5 general payments to Dr. Schwartz from 3 drug and device companies from 2017 to 2025. Consulting fees make up the largest share, 86% of the total. Celgene Corporation paid the most, $1,665.

Dmand AI lists 4 awards for Dr. Schwartz, most recently NCQA DRP in 2015.

Dr. Schwartz graduated from New York Institute of Technology College of Osteopathic Medicine - Old Westbury in 1986. Dr. Schwartz is a member of AMA and AOA.

Dr. Schwartz is in network with 18 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 13. Check the plan with the practice before a visit.